HRS9950
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for HRS9950, covering 2024-11-05 to 2024-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Clinical Study of the Efficacy and Safety of HRS9950 Tablets in Chronic Hepatitis B Patients Who Are Virologically Suppressed on Nucleoside or Nucleotide Analogues (NAs) [Phase 2]